Skip to main content
Year archive

Alligator Bioscience — 2021 filings

All 73 regulatory filings released by Alligator Bioscience (ATORX) in 2021, sourced directly from the official regulator.

73 Filings
2021 Period
2021 filings (73)
Filing Released Lang
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-30 English
Change in number of shares and votes in Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-12-30 English
Ändring av antalet aktier och röster i Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-12-30 Swedish
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-27 English
Sista dag för handel med BTA i Alligator
Capital/Financing Update
2021-12-16 Swedish
Last day of trading in paid subscription shares (Sw. BTA) in Alligator
Capital/Financing Update
2021-12-16 English
Alligator carries out a directed issue of shares to guarantors in connection with the completed rights issue
Share Issue/Capital Change
2021-12-02 English
Alligator genomför riktad nyemission av aktier till garanter i samband med den genomförda företrädesemissionen
Capital/Financing Update
2021-12-02 Swedish
Alligator offentliggör slutligt utfall i företrädesemission
Capital/Financing Update
2021-12-01 Swedish
Alligator announces final outcome of rights issue
Share Issue/Capital Change
2021-12-01 English
Alligator announces preliminary outcome of rights issue
Share Issue/Capital Change
2021-11-29 English
Alligator offentliggör preliminärt utfall i företrädesemission
Capital/Financing Update
2021-11-29 Swedish
The subscription period in Alligator Bioscience's rights issue begins today
Capital/Financing Update
2021-11-12 English
Idag börjar teckningstiden för Alligator Biosciences företrädesemission
Capital/Financing Update
2021-11-12 Swedish
Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam
Regulatory Filings
2021-11-08 English
Alligator Bioscience meddelar att bolaget inleder en prövarinitierad klinisk fas I-studie vid Erasmus MC University Medical Center i Rotterdam
Regulatory Filings
2021-11-08 Swedish
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-11-08 English
Kommuniké från extra bolagsstämma i Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-11-08 Swedish
Nomination Committee appointed in respect of AGM 2022 in Alligator Bioscience AB
Board/Management Information
2021-11-03 English
Valberedning utsedd inför årsstämma 2022 i Alligator Bioscience AB
AGM Information
2021-11-03 Swedish
Alligator ingår avtal om teckningsförbindelser med styrelseledamöter och ledande befattningshavare
Capital/Financing Update
2021-10-22 Swedish
Alligator enters into agreements on subscription commitments with board members and senior executives
Major Shareholding Notification
2021-10-22 English
Earnings Release 2021
Earnings Release 9M 2021
2021-10-21 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-10-21 English
Alligator meddelar att första patienten doserats i klinisk fas II-studie i samarbete med Shanghai Henlius Biotech, Inc. och AbClon, Inc.
Regulatory Filings
2021-10-21 Swedish
Alligator Announces First Patient Dosed in Phase II Clinical Trial with Shanghai Henlius Biotech, Inc. & AbClon, Inc.
Regulatory Filings
2021-10-21 English
Invitation to the Presentation of Alligator Bioscience´s Interim Report January - September 2021 on October 21, 2021
Report Publication Announcement
2021-10-15 English
Inbjudan till presentation av Alligator Biosciences delårsrapport januari – september 2021 den 21september 2021
Report Publication Announcement
2021-10-15 Swedish
Notice of extraordinary general meeting in Alligator Bioscience AB
AGM Information
2021-10-07 English
Kallelse till extra bolagsstämma i Alligator Bioscience AB
AGM Information
2021-10-07 Swedish
Alligator carries out a 100 percent secured rights issue of approximately SEK 257 million
Share Issue/Capital Change
2021-10-07 English
Alligator genomför en till 100 procent säkerställd företrädesemission om cirka 257 MSEK
Capital/Financing Update
2021-10-07 Swedish
Alligator Bioscience meddelar att första patienten doserats i den kliniska fas-II-studien OPTIMIZE-1 som utvärderar mitazalimab i kombination med mFOLFIRINOX för behandling av bukspottkörtelcancer
Regulatory Filings
2021-09-30 Swedish
Alligator Bioscience Announces First Patient Dosed in OPTIMIZE-1 Phase II Clinical Trial Evaluating Mitazalimab in Combination with mFOLFIRINOX for the Treatment of Pancreatic Cancer
Regulatory Filings
2021-09-30 English
Alligator Bioscience undersöker finansieringsalternativ för att stödja fas II-studier för Mitazalimab, fas II-förberedelser för ATOR-1017 samt utvecklingen av andra pipelinekandidater
Capital/Financing Update
2021-09-02 Swedish
Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipeline
Capital/Financing Update
2021-09-02 English
Alligator Bioscience ingår immunonkologiskt forskningssamarbete och licensavtal med Orion Corporation
Regulatory Filings
2021-08-18 Swedish
Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation
Capital/Financing Update
2021-08-18 English
Regulatory Filings 2021
Regulatory Filings
2021-07-13 English
Alligator Bioscience presenterar positiva fas I-data på ASCO för 4-1BB-antikroppen ATOR-1017
Regulatory Filings
2021-06-04 Swedish
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017
Earnings Release FY 2021
2021-06-04 English
Kommuniké från årsstämma den 1 juni 2021 i Alligator Bioscience AB
AGM Information
2021-06-01 Swedish
Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021
AGM Information
2021-06-01 English
Styrelseledamot i Alligator Bioscience AB avgår på egen begäran
Board/Management Information
2021-04-30 Swedish
Board member in Alligator Bioscience resigns at his own request
Board/Management Information
2021-04-30 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-27 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-27 English
Kallelse till årsstämma i Alligator Bioscience AB
AGM Information
2021-04-26 Swedish
Notice of annual general meeting in Alligator Bioscience AB
AGM Information
2021-04-26 English
Valberedningens förslag till styrelse inför årsstämman 2021 i Alligator Bioscience AB
AGM Information
2021-04-22 Swedish
The Nomination Committee’s proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
Board/Management Information
2021-04-22 English
Alligator Bioscience flyttar fram årsstämman till 1 juni 2021
Report Publication Announcement
2021-04-03 Swedish
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
AGM Information
2021-04-03 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-04-01 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-04-01 English
Alligator Bioscience appoints Søren Bregenholt as new CEO
Board/Management Information
2021-03-18 English
Alligator Bioscience utser Søren Bregenholt till ny VD
Board/Management Information
2021-03-18 Swedish
Annual Report 2020
Annual Report FY 2020
2021-03-18 Swedish
Annual Report 2020
Annual Report FY 2020
2021-03-18 English
Ändring av antalet aktier och röster i Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-02-26 Swedish
Change in number of shares and votes in Alligator Bioscience AB
Declaration of Voting Results & Voting Rights Announcements
2021-02-26 English
Investor Presentation 2021
Investor Presentation
2021-02-26 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-26 English
Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA)
Share Issue/Capital Change
2021-02-23 English
Alligator Bioscience AB: Sista dag för handel med BTA
Report Publication Announcement
2021-02-23 Swedish
Alligator Biosciences företrädesemission övertecknad
Share Issue/Capital Change
2021-01-27 Swedish
Alligator Bioscience’s rights issue oversubscribed
Share Issue/Capital Change
2021-01-27 English
Larger shareholder and board member transfer subscription rights free of charge to qualified investors
Capital/Financing Update
2021-01-21 English
Större aktieägare och styrelseledamot överlåter teckningsrätter vederlagsfritt till kvalificerade investerare
Share Issue/Capital Change
2021-01-21 Swedish
Alligator Bioscience tillsätter Chief Scientific Officer
Board/Management Information
2021-01-15 Swedish
Alligator Bioscience appoints Chief Scientific Officer
Board/Management Information
2021-01-15 English
Idag inleds teckningsperioden i Alligator Biosciences företrädesemission
Share Issue/Capital Change
2021-01-11 Swedish
The subscription period in Alligator Bioscience’s rights issue commences today
Share Issue/Capital Change
2021-01-11 English